Inactive Instrument

Epirus Biopharmaceuticals Inc Share Price Other OTC

Equities

Duration

Period

Style

Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	09/10/18	CI
Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	30/01/18	CI
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19/01/18	CI
Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	17/01/18	CI
Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	11/12/17	CI
Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	19/09/16	CI
EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from S&P TMI Index	05/08/16	CI
EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from NASDAQ Composite Index	03/08/16	CI
EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations	25/07/16	CI
EPIRUS Biopharmaceuticals, Inc. Filed for Bankruptcy	25/07/16	CI
EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination	01/07/16	CI
Polpharma S.A. completed the acquisition of EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc..	29/06/16	CI
Polpharma S.A. entered into a binding term sheet to acquire EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc. for $3.5 million.	13/06/16	CI
EPIRUS Biopharmaceuticals, Inc. Announces Executive Changes	09/05/16	CI
EPIRUS Biopharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	28/03/16	CI

EPIRUS Biopharmaceuticals, Inc. is in bankruptcy.

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.77%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.24%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.44%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.01%	18.12B
MEDPACE HOLDINGS, INC.	+30.56%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.82%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.35%	11B